{"version":"1.0","type":"link","title":"FDA Approval Summary: Cabozantinib for Differentiated Thyroid Cancer.","author_name":"Duke ES 외","author_url":"https://prs-insight.online/author/Duke%20ES","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/147206","thumbnail_width":1200,"thumbnail_height":630}